News
Scotland’s new Health Framework Plan overlooks simple ways to reduce alcohol consumption,’ says expert The preventative ...
Cloud Computing in Healthcare Market sees 16% CAGR fueled by smarter, connected health tools by 2030
The global cloud computing in healthcare market is set to witness a growth rate of 16% in the next 5 years. Rising adoption ...
Lentiviral Vector CDMO Market sees 8% CAGR as gene therapy pipeline and R&D investments grow by 2030
The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...
A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...
The microbiology culture market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving growth ...
Data show urgent need for site-neutral payment reform WASHINGTON, DC / ACCESS Newswire / July 24, 2025 / A groundbreaking peer-reviewed study published today in Journal of Market Access & Health ...
Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer Both executives possess proven track records in strategic execution and deal-making and will help drive ...
New Directors bring deep commercial, operational, and transaction experience to the Board Mechelen, Belgium; July 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the ...
Novel AI-powered laboratory test for diagnosis of Barrett's esophagus, with or without dysplasia SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...
Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million.Joining existing investors Hesta, Host Plus, CSL and QIC ...
SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results